Varivax vaccine with diluents
Ended Awarded
- Contract number
- SPE2DR26FBSA3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,179
Award facts
- Contract value 100% obligated
- $61,179.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Varivax vaccine with diluents, valued at $61,179.00 with a firm fixed price structure. This delivery order, designated as a competitive award with no set-aside provisions, is scheduled for completion by December 10, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support mechanism.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, is a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies through competitive procurement processes. This Varivax vaccine delivery order supports the Defense Health Agency and other federal healthcare systems requiring immunization resources for military personnel and beneficiaries, reinforcing AmerisourceBergen's role as a primary pharmaceutical supplier within the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBSA3?
SPE2DR26FBSA3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FBSA3 worth?
The government has obligated $61,179 on SPE2DR26FBSA3.
Is contract SPE2DR26FBSA3 an order under another contract?
Yes. SPE2DR26FBSA3 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBSA3 competed?
The extent of competition for SPE2DR26FBSA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award